Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Ambarish Pandey MD, MSCS

Ambarish Pandey MD, MSCS

Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas

Disclosures

Dr. Pandey has received research support from the National Institute on Aging GEMSSTAR Grant (1R03AG067960-01), and the National Institute on Minority Health and Disparities (R01MD017529). 

Dr. Pandey has received grant funding from Applied Therapeutics and Gilead Sciences; has received honoraria outside of the present study as an advisor/consultant for Tricog Health Inc, Lilly USA, Rivus, Cytokinetics, and Roche Diagnostics, and has received nonfinancial support from Pfizer and Merck. 

Recent Contributions to PracticeUpdate:

  1. Clinical Utility of Cardiovascular Risk Scores for the Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1RA or SGLT2i Therapy

Most Read This Week

Recently Updated